JPS4830376B1 - - Google Patents
Info
- Publication number
- JPS4830376B1 JPS4830376B1 JP12645270A JP12645270A JPS4830376B1 JP S4830376 B1 JPS4830376 B1 JP S4830376B1 JP 12645270 A JP12645270 A JP 12645270A JP 12645270 A JP12645270 A JP 12645270A JP S4830376 B1 JPS4830376 B1 JP S4830376B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12645270A JPS4830376B1 (es) | 1970-12-29 | 1970-12-29 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12645270A JPS4830376B1 (es) | 1970-12-29 | 1970-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS4830376B1 true JPS4830376B1 (es) | 1973-09-19 |
Family
ID=14935553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12645270A Pending JPS4830376B1 (es) | 1970-12-29 | 1970-12-29 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS4830376B1 (es) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5128051U (es) * | 1974-08-22 | 1976-03-01 | ||
| US11510901B2 (en) | 2018-01-08 | 2022-11-29 | Epicentrx, Inc. | Methods and compositions utilizing RRx-001 combination therapy for radioprotection |
| US11576895B2 (en) | 2016-01-11 | 2023-02-14 | Epicentrx, Inc | Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone |
| US11660286B2 (en) | 2011-10-07 | 2023-05-30 | Epicentrx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
| US11701351B2 (en) | 2015-10-29 | 2023-07-18 | Epicentrx, Inc. | Treatment of gliomas using organonitro compound combination therapy |
| US11744859B2 (en) * | 2017-07-07 | 2023-09-05 | Epicentrx, Inc. | Compositions and methods for parenteral administration of therapeutic agents |
| US11925617B2 (en) | 2005-08-12 | 2024-03-12 | Northrop Grumman Systems | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
-
1970
- 1970-12-29 JP JP12645270A patent/JPS4830376B1/ja active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5128051U (es) * | 1974-08-22 | 1976-03-01 | ||
| US11925617B2 (en) | 2005-08-12 | 2024-03-12 | Northrop Grumman Systems | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| US11660286B2 (en) | 2011-10-07 | 2023-05-30 | Epicentrx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
| US11701351B2 (en) | 2015-10-29 | 2023-07-18 | Epicentrx, Inc. | Treatment of gliomas using organonitro compound combination therapy |
| US11576895B2 (en) | 2016-01-11 | 2023-02-14 | Epicentrx, Inc | Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone |
| US11744859B2 (en) * | 2017-07-07 | 2023-09-05 | Epicentrx, Inc. | Compositions and methods for parenteral administration of therapeutic agents |
| US11510901B2 (en) | 2018-01-08 | 2022-11-29 | Epicentrx, Inc. | Methods and compositions utilizing RRx-001 combination therapy for radioprotection |